Dihydroetorphine hydrochloride sublingual tablets
Indication
This product is suitable for the analgesia of various severe pains, such as traumatic pain, postoperative pain, acute abdominal pain, dysmenorrhea, and advanced cancer pain, including severe pain that is not responsive to morphine or pethidine.
Precautions
1. It is contraindicated for patients with unconsciousness due to brain trauma or impaired lung function; 2. It is not suitable for use for non-severe pain such as toothache, headache, rheumatism, hemorrhoid pain or pain caused by minor local tissue trauma; 3. It should be used with caution by the elderly; 4. It is contraindicated for infants, young children and immature newborns.
Special Population Medication
Precautions for children: Forbidden to use in infants and immature newborns. Precautions for the elderly: Use with caution in the elderly.
Packaging Specification
20 μg
Manufacturer
Beijing Wellso Pharmaceutical Co., Ltd.
-
Founded in:
2000-06-28 -
Address:
No. 1, Jinguang North Street, Liangxiang Town Industrial Development Zone, Fangshan District, Beijing -
Tax NO.:
911100007226097157 -
Registered Funds:
105.6005 million yuan -
Website:
-
Email: